A Clinical Study of MK-1045 in People with Lupus or Rheumatoid Arthritis (MK-1045-004)

Trial Identifier:	1045-004
Sponsor:	MSD
Start Date:	February 2026
Primary Completion Date:	July 2029
Study Completion Date:	July 2029
Condition:	Rheumatoid Arthritis; Lupus

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	Protocol Plain Language Summary

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.